ABSTRACT Because temperature plays an important role on progression and transmission of disease caused by Perkinsus marinus in the field, the effects of triclosan on the viability of P. marinus meronts (trophozoites) and oyster hemocytes were tested at a range of environmental relevant temperatures. Additionally, we examined the triclosan effect on reactive oxidative intermediate production (ROI) by oyster hemocytes and tested the efficacy of treating infected oysters with triclosan in eliminating/ reducing P. marinus infection in a pilot experiment. When P. marinus cultivated at 13°C, 20°C, and 28°C was exposed to triclosan at corresponding temperatures, 2-10 mM triclosan killed 10-30% at 20°C and $40% at 28°C, but #10% at 13°C. When exposure of P. marinus cultivated at 28°C to triclosan at 26°C, similar mortality was noted as those recorded at 28°C. Treating hemocytes from oysters maintained at 13°C, 20°C, or 26°C with 2, 5, 10 mM triclosan at corresponding temperatures, killed 2% to 13% at 13°C and 6 to16% at 20°C. No mortality occurred in hemocytes exposed to 2-10 mM triclosan at 26°C. However, at the highest temperature and triclosan concentration tested (28°C, 10 mM triclosan), hemocyte mortality exceed 30%. Exposure of hemocytes to triclosan concentrations of 2-10 mM for 4 h at 4°C significantly reduced the ROI production in hemocytes in a dose-dependent response. Treating P. marinus infected oysters with 300 and 600 mg triclosan/oyster daily for 8 wk, significantly slowed the disease progression.
INTRODUCTION
The protozoan parasite Perkinsus marinus, causative agent of Dermo disease, is presently the most prevalent and destructive parasite of the eastern oyster Crassostrea virginica (Gmelin 1791) in midAtlantic water of the United States. It has decimated oyster populations along the Atlantic coast and the Gulf of Mexico for at least 30 y. The impact of Dermo disease on the Chesapeake Bay has been particularly devastating in that current oyster populations are now less than 1% of historic levels. The basis of P. marinus's virulence is presently unclear. One unusual aspect of P. marinus is that unlike other parasitic protozoans, it is able to synthesize a range of saturated and unsaturated fatty acids, including the essential fatty acid, arachidonic acid (AA, (Chu et al. 2002) , a precursor for a series of eicosanoids involved in many biochemical and physiological processes. Perkinsus marinus has a nonphotosynthetic plastid in the biflagellate zoospore stage (Perkins 1996) .The presence of a plastid in Perkinsus spp. was recently confirmed with molecular and ultrastructural evidence (Teles-Grilo et al. 2007 , Stelter et al. 2007 ). The acyl elongation reaction in the meront (trophozoite) stage of this parasite is catalyzed by a FAE1-like ketoacyl-CoA synthase class of condensing enzyme previously only reported in higher plants and algae (Venegas-Caleron et al. 2007 ). Thus, P. marinus likely uses type II fatty acid synthase pathway for fatty acid synthesis.
Triclosan, a specific inhibitor of type II class of fatty acid synthases, is a widely used and largely unregulated antimicrobicide. It is contained in many daily use household products such as soap, shampoo, toothpaste, and mouthwash. Triclosan inhibits the growth and disease progression of Plasmodium spp. via inhibition of fatty acid synthesis (Surolia & Surolia 2001) . Our previous results revealed that whereas causing minimal effect on oyster hemocyte viability, triclosan not only inhibits growth and greatly reduces viability of in vitro cultured P. marinus meronts, but it also inhibits the parasite's fatty acid synthetic ability .
Both field and laboratory studies have shown that temperature plays an important role in Dermo disease progression and transmission. Disease prevalence and intensity are positively correlated with temperature (Chu 1996 , Chu & Volety 1997 , Burreson & Ragone-Calvo 1996 , Ragone-Calvo et al. 2003 . In vitro, P. marinus meronts proliferate and develop rapidly to prezoosporangium stage at temperatures of 20°C to 30°C (Chu & Greene 1989) . Furthermore, temperature significantly affects the lipid metabolism in the parasite. Relevant to rapid disease progression and advancement at high temperature, fatty acid synthesis rates and exogenous lipid incorporation and metabolism in P. marinus meronts are positively correlated with temperature (Chu et al. 2003 , Lund et al. 2004 . The objective of the present study was to test the influence of temperature on effects of triclosan on the viability of P. marinus meronts. To address concerns about potential toxic effect on host cells, the effect of triclosan on oyster hemocyte viability at a range of environmentally relevant temperatures and on hemocyte reactive oxidative intermediate production were also examined. Additionally, the efficacy of treating infected oysters with triclosan in eliminating/reducing P. marinus infection was tested in a pilot experiment.
MATERIALS AND METHODS

Experiments
Effects of Triclosan on Perkinsus marinus Meronts and Oyster
Hemocytes at Different Temperatures 20, Lund et al. 2004) . Medium was then sterilized by 0.2-mm filtration and stored at 4°C until use. Meronts were inoculated at a concentration of 1 3 10 6 /mL and cultivated in 10-mL aliquots of medium in T-10 tissue culture flasks at 13°C, 20°C, and 28°C. Meronts at exponential growth phase (7 days post inoculation) were harvested to test the effect of triclosan on their viability corresponding to their cultivation temperatures.
To test the effect of triclosan on oyster hemocyte's viability at different temperatures, oyster were maintained in a flowthrough flume with ambient estuarine water (York River, VA, salinity ¼ 16-26 psu). A few days (5-6 days) after ambient temperature reached 13°C, 20°C, or 26°C, 8-14 oysters were selected from the flume randomly for hemolymph sampling. Approximately 1.0 mL of hemolymph was withdrawn from each oyster. All hemolymph samples were stored individually in microtubes at 4°C and examined microscopically for any contamination with bacteria or gametes. If contamination was visible the sample was discarded. Non-contaminated hemolymph samples were pooled and adjusted to a concentration of 2.0-3.0 3 10 6 cells/mL of hemolymph by centrifugation (1,000 rpm ¼ 200 3 g) for 20 min 4°C and hemocytes were tested for viability after incubation with different concentrations of triclosan. To test effect of triclosan on oyster hemocytes at the temperature 28°C, oysters were acclimated to 28°C and maintained at the same temperature for up to 2 wk before hemocytes were sampled from oysters for viability assays.
The effects of triclosan on the viability of P. marinus meronts and oyster hemocytes were assessed using the MTS/PMS assay. Briefly, 100 mL of 7 day old meront culture containing 3.0 3 10 6 cells/mL medium or 100 mL of pooled hemolymph containing 2.0-3.0 3 10 6 cells/mL of hemolymph was pipetted to each well (n ¼ 8) of a 96-well microplate. Two and a half micro liters of triclosan stock solution in EtOH (0 mM, 0.08 mM, 0.2 mM, or 0.4 mM) were then added to each well (n ¼ 8 wells per triclosan concentration) to achieve 4 triclosan treatment groups with a final triclosan concentration of 0 mM, 2 mM, 5 mM, and 10 mM respectively. The final ethanol concentration was 0.5%. The 96-well microplate was incubated at temperatures corresponding to the oyster maintenance (13°C, 20°C, 26°C, and 28°C) and P. marinus cultivation (13°C, 20°C, and 28°C) temperatures for 24 h in the dark. Additionally, triclosan effects on meronts cultured at 28°C were also tested at 26°C and hemocytes from oysters maintained at 26°C were also tested at 28°C. After 24 h incubation, viability of P. marinus meronts and oyster hemocytes were assessed employing the MTS/PMS assay. Briefly, 20 mL of the MTS/PMS working solution was added to each well, mixed well and incubated again in the dark for 3 h at corresponding temperatures (13°C, 20°C, 26°C, or 28°C). The absorbance (optical density, OD) of formazan, the reduction product of MTS/PMS, was measured at 450 nm using a Tecan GENios microplate reader (Maennedorf, Switzerland). Instrument control and data acquisition by MS-Excel was provided by the computer software XFLUOR4 V 4.50 (Tecan, Maennedorf, Switzerland). The percentage of viable cells is expressed as the percentage of the OD measured for the control.
The MTS/PMS assay assesses cell viability and proliferation based on dehydrogenation of oxidizable substrates by dehydrogenase of live cells coupled with the reduction of the tetrazolium dye. It indirectly measures the number of viable cells, because the amount of mitochondrial dehydrogenase present in the samples is directly proportional to the number of viable cells. This assay has been applied to measure viability of other cells, including P. marinus meronts and oyster hemocytes (Dungan & Hamilton 1995 , Volety et al. 1999 .
The 3,(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) was obtained from Promega (CellTiter 96 AQ, Cat.#G1111, Madison, WI, USA) and phenazine methosulfate (PMS) was obtained from Sigma (P9625, St. Louis, MO). MTS and PMS reagents were prepared according to manufacturers' instructions (Promega, CellTiter 96 Aqueous NonRadioactive Cell Proliferation Assay, Technical Bulletin #169, Promega Corporation, Madison, WI).
Effect of Triclosan on Reactive Oxidative Intermediate (ROI) Production in Oyster Hemocytes
The ROI production by triclosan treated hemocytes were assessed employing a chemiluminescence assay modified from Bramble and Anderson (1998) . Briefly, hemocytes were first treated with different concentrations of triclosan (0 mM, 2 mM, 5 mM, or 10 mM triclosan n ¼ 4 per triclosan concentration) at 4°C for 4 h, then the zymosan stimulated ROI production in hemocytes was quantified by luminometry. Uncontaminated pooled hemolymph drawn from 20 oysters maintained in a flowthrough flume with ambient estuarine water (York River, VA, salinity ¼ 16-26 psu) in January 2006 (temperature ¼ 4-8°C) was centrifuged at 200 3 g for 10 min at 4°C. After carefully removing the plasma, hemocytes were gently resuspended in ASW of salinity 20. The resuspended hemocytes were dispensed into 4 Eppendorf tubes and triclosan was added to each tube at concentrations of 0 mM, 2 mM, 5 mM, or 10 mM using ethanol as a carrier. The final ethanol concentration was 0.5%. After incubation at 4°C for 4 h the tubes containing the hemocytes were centrifuged, the supernatant was removed and hemocytes were resuspended in fresh ASW to a concentration of 7 3 10 6 hemocytes/mL. One hundred microliters of the hemocyte suspension was added each well of a white flat bottomed 96 well microtiter plate (7 3 10 5 hemocytes/well, n ¼ 8 wells/ treatment) along with 70 mL luminol working solution. The final luminol concentration was 5 mM. The plate was then read on a GENios microplate reader in luminometry mode for 5 cycles (integration time ¼ 1,000 ms, gain ¼ 150, kinetic interval ¼ 142 s) to determine baseline chemiluminescence. Afterward, 20 mL of zymosan working solution (1 mg/mL) was added to 4 wells of each treatment to stimulate an ROI response. The remaining 4 wells from each treatment received 20 mL ASW and served as unstimulated controls. The microplate was then returned to the plate reader and chemiluminescence was recorded in kinetics mode for an additional 20 cycles (45 min).
Effects of Triclosan on Dermo Disease Progression in Infected Oysters
Triclosan is a relatively hydrophobic molecule that has low solubility in sea water. Thus direct addition of triclosan to seawater containing oysters may be an inefficient way to deliver the drug. An experiment was designed to test whether algal feed could be used as a delivery device for the drug by adding triclosan dissolved in ethanol to algal feed used to maintain oysters in closed circulation systems. Concentrated algae (Instant Algae Shellfish diet 1800, Reed Mariculture, Campbell, CA) were used for delivering triclosan to the oysters. Triclosan was dissolved in EtOH then added to algae (0.1% EtOH (v/w) in all treatment feeds) and stirred at room temperature (20°C) overnight. The incorporation of triclosan into algae was determined by gas chromatography equipped with a flame ionization detector (GC/FID). Triclosan incorporation efficiency was determined to be >85%. Three concentrations of triclosan in algae, were fed to Perkinsus-infected oysters (Crassostrea virginica, DEBBIE strain, shell length ¼ 40-70 mm). The experimental oysters had been previously maintained in the York River (VA) for more than a year before the start of the experiment in July 2005. Oysters were maintained in 1 mmfiltered 20°C York River water (YRW) at a density of 20 individuals per 40 L tank with three replicate tanks per treatment. Water was changed three times per week and oysters were fed 0.2 g algae per individual daily. Oysters were treated with 0, 150, 300, or 600 mg triclosan per oyster daily by feeding them a combination of triclosan-sorbed algae and nonsorbed algae (a total of 0.2 g per oyster). Fifteen oysters were sampled prior to the start of the experiment to determine initial P. marinus infection levels. After 8 wk 10 oysters from each replicate tank were sampled (30 per treatment group) for determination of P. marinus body burden (# of parasite cells per g of wet oyster tissue weight [g ww], Mean ± SE, n ¼ 30) and condition index. To test whether long term triclosan exposure causes death in oysters, triclosan exposure was extended an additional 5 wk.
Statistical Analysis
Analysis of Variance (ANOVA) was conducted on all data to determine differences among treatments. When results were significant (P < 0.05), Tukey's test was used to determine significant differences between each sampling point.
RESULTS
Effects of Triclosan on Perkinsus marinus Meronts and Oyster Hemocytes: A Comparison at Different Temperatures
Temperature significantly affected the effect of triclosan on the viability of Perkinsus marinus meronts. Perkinsus marinus meront cells were more susceptible to the effect of triclosan at higher temperatures (Table 1) . A concentration of 2-10 mM triclosan (0.6, 1.5, and 2.9 mg/mL) effectively killed 10% to 30% of meronts at 20°C, and up to 40% at 26°C and 28°C (Table 1) . But, P. marinus has a better triclosan tolerance at 13°C: viability was reduced only slightly (4% to 10%), when P. marinus meronts were exposed to 2-10 mM triclosan at this temperature (Table 1 ).
The effect of triclosan on hemocyte viability did not change much with temperature (Table 2) . Exposure of oyster hemocytes to 2, 5, or 10 mM triclosan at 13, and 20°C resulted in mortality of 2% to16%. No mortality occurred in hemocytes exposed to 2-10 mM triclosan at 26°C. Only at the highest temperature and triclosan concentration tested (28°C, 10 mM triclosan) did hemocyte mortality exceed 30% (Table 2) . Similarly, mortality of > 30% occurred when hemocytes from oysters maintained at 26°C were exposed to 10 mM triclosan at 28°C (data not shown).
Effect of Triclosan on Reactive Oxidative Intermediate (ROI) Production in Oyster Hemocytes
In all treatments hemocytes stimulated with zymosan produced a significant chemiluminescence response (ROI burst) relative to the unstimulated controls (Fig. 1) . A dose-dependent response of chemiluminescence production with significant treatment effect was noted when hemocytes were exposed to 0 mM, 2 mM, 5 mM, or 10 mM triclosan at 4°C, a temperature similar to the oyster maintenance temperature when the assays were conducted. These results suggest that triclosan exposure significantly reduced the ROI production as measured by chemiluminescence assay.
Effects of Triclosan on Dermo Disease Progression in Infected Oysters
At the start of the experiment, the initial parasite burden in infected oysters was 34,000 ± 44,000 cells/g ww (n ¼ 15, Mean ± SD). Although all of the triclosan treatment groups exhibited higher body burdens relative to the initial sampling, treating P. marinus infected oysters with triclosan concentrations of 300 and 600 mg/oyster daily for 8 wk, significantly slowed down the disease progression (Fig. 2) as indicated by lower parasite burdens in the groups treated with 300 and 600 mg triclosan/ oyster/day.
The control treatment had the highest body burden (252,513 ± 120,857 cells/g ww) of all treatments and the 300-and 600-mg treatments (169,657 ± 63,825 and 213,785 ± 71,551 cells/g ww) had significantly lower body burdens than the control. The 150 mg/day treatment body burdens (229,667 ± 53,957 cells/g ww) were intermediate in intensity between the control and the higher dosage treatments, but not significantly different from either. Oyster mortality was low when triclosan exposure was extended to 14 wk of exposure. Mortalities were 3.3%, 3.3%, 1.6%, and 8.3% for the control, 150 mg, 300 mg, and 600 mg Effect of triclosan on the viability of Perkinsus marinus meronts at 13°C, 20°C, 26°C and 28°C. Viability (Mean % SD, n$ 8) of triclosan treated P. marinus meronts is expressed as the % of the control (P.marinus meronts incubated with 0 mM triclosan). Letters denote significant differences at the P < 0.05 level. Effect of triclosan on the viability of oyster hemocytes at 13, 20, 26 and 28°C. Viability (Mean % SD, n $ 8) of triclosan treated hemocytes is expressed as the % of the control (hemocytes incubated with 0 mM triclosan). Letters denote significant differences at the P < 0.05 level. 
DISCUSSION
Results obtained from the present study are consistent with our previous findings . Triclosan greatly reduces cell viability of in vitro cultured Perkinsus marinus, but it has much less effect on oyster hemocyte viability. These effects are consistent with a mode of action in which triclosan acts as an inhibitor of type II fatty acid synthases, which has been found in bacteria and several Apicomplexan protists. Triclosan inhibits the growth and disease progression of Plasmodium spp. via inhibition of fatty acid synthesis (Surolia & Surolia 2001) . Triclosan killed procyclic and bloodstream forms of Trypanosoma brucei in culture and inhibited its fatty acid remodeling and myristate exchange pathway (Paul et al. 2004 ). The in vitro tested concentrations are 1,000 times lower than the level allowed by FDA in daily use hygiene products such as toothpaste and mouthwash (3 g/L versus 2.9 mg/L for 10 mM).
Temperature plays an important role in regulating the interaction of Perkinsus marinus and its host, the eastern oyster, Crassostrea virginica (Andrews 1988 , Chu & La Peyre 1993 , Burreson & Ragone-Calvo 1996 , Ragone-Calvo et al. 2003 . Disease progression and transmission in the field is positively correlated with temperature (Andrews 1988 , Burreson & Ragone-Calvo 1996 . High temperatures favor P. marinus development at in vitro conditions (Chu & Greene 1989 ) and a laboratory study has shown that disease prevalence and intensity are positively correlated with experimental temperatures (Chu & La Peyre 1993 ). Previously, we tested the effect of temperature on the uptake and metabolism of fluorescent lipid analogs and fatty acid synthesis by P. marinus meronts (Chu et al. 2003) . It was found that: (1) low metabolism and bioconversion of incorporated fluorescent lipid analogs at low temperatures (10°C < 18°C < 28°C); (2) fatty acid synthesis rate decreases with decreasing cultivation temperatures (10°C < 18°C < 28°C), and (3) the synthesis rate for the eicosanoid precursor, arachidonic acid, is suppressed at 10°C (Lund et al. 2004) . Surprisingly, results of the present study showed that P. marinus meront cells were more susceptible to the effect of triclosan at higher temperatures, but had a better triclosan tolerance at 13°C. It is not known whether it is because of temperature effects on the solubility of this hydrophobic drug. Triclosan has a solubility in water of 10 mg/L at 20°C (Yalkowsky & He 2003) , over 3-fold higher than the highest triclosan concentration tested in this study (10 mM ¼ 2.9 mg/L). The profound effect of triclosan at high temperature on P. marinus may be good for infected oysters.
Triclosan exposure at concentrations 2-10 mM caused much higher mortality in P. marinus meronts than in hemocytes at 20°C, 26°C, and 28°C. The high mortality recorded in hemocytes derived from oysters maintained at 28°C and exposed to 10 mM triclosan is believed to be caused by a synergistic effect of high triclosan concentration and temperature stress, because hemocytes tested at 26°C and the same triclosan concentration (10 mM) did not exhibit any mortality. It has been reported that phagocytic activity of oyster hemocytes is reduced at temperatures greater than 25°C (Chu & LaPeyre 1993) . Oysters lack a specific immune response, but possess various humoral and cellular factors important in defense against pathogenic microbes. Cell-mediated defense mechanisms are mainly carried out by hemocytes in oysters (Chu 2000) . Hemocytes are considered to be the primary cellular effectors because of their ability to recognize, phagocytose and destroy a spectrum of microbes including bacteria, yeast and Perkinsus marinus meronts (La Peyre et al. 1995 , Chu 2000 . The synergistic effects of lysosomal enzymes and cytotoxic oxygen metabolites (e.g., O 2 -, H 2 O 2, 1 O 2 , NO) produced from respiration burst during phagocytosis are critical for the killing of the phagocytosed or encapsulated pathogens (see review : Chu 2000) . Significant reduction of ROI production in triclosan treated oyster hemocytes at in vitro conditions suggests an effect of triclosan on oyster physiological functions including immune defense system. However, in the present study the effect of triclosan on ROI response was tested only at a temperature (4°C) similar to the oyster maintenance temperature at the time when Different letters denote significant differences at the P < 0.05 level.
hemolymph was sampled. Further studies are needed to test the impact of triclosan on ROI production at a range of temperatures similar to the hemocyte viability studies in the present study to determine whether temperatures influence the triclosan effect on ROI production. Moreover, it would be interesting to pursue in the future a study that follows the ROI response along with Dermo progression at a range of temperatures.
Results of the present study suggest that treatment with triclosan can reduce Perkinsus marinus infection intensities in infected oysters relative to untreated oysters. The 300 mg triclosan/day treatment appears to exhibit the most desirable responses of the treatments tested: lowest P. marinus infection level and lowest mortality. The in vivo tested concentrations, 150, 300, and 600 mg per day (0.52, 1.04, and 2.07 m mole respectively) is 10-20 times lower than the allowed level by FDA in daily use of toothpaste (7.5 mg/dose). However, further experiments are needed to confirm these results and modifications to the protocol will probably be required to actually reduce infection intensities, rather than just reduce the rate of replication under conditions conducive to parasite proliferation. Furthermore, it is necessary to determine if there is any triclosan bioaccumulation in oysters after feeding with triclosan sorbed algae. Therefore, although our results suggest that this drug may be useful in treating infected oysters, further toxicology studies utilizing infected and uninfected oysters will be required to ultimately determine the utility of using triclosan to treat Dermo infections in hatchery and research environs.
